[go: up one dir, main page]

GT199200009A - Composicion farmaceutica y su utilizacion en el tratamiento contra el cancer e infecciones viricas. - Google Patents

Composicion farmaceutica y su utilizacion en el tratamiento contra el cancer e infecciones viricas.

Info

Publication number
GT199200009A
GT199200009A GT199200009A GT199200009A GT199200009A GT 199200009 A GT199200009 A GT 199200009A GT 199200009 A GT199200009 A GT 199200009A GT 199200009 A GT199200009 A GT 199200009A GT 199200009 A GT199200009 A GT 199200009A
Authority
GT
Guatemala
Prior art keywords
quinone
pharmaceutical composition
viral infections
against cancer
treatment against
Prior art date
Application number
GT199200009A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199200009A publication Critical patent/GT199200009A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/04Nitro compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/15Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B1/00Dyes with anthracene nucleus not condensed with any other ring
    • C09B1/02Hydroxy-anthraquinones; Ethers or esters thereof
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0033Blends of pigments; Mixtured crystals; Solid solutions
    • C09B67/0034Mixtures of two or more pigments or dyes of the same type
    • C09B67/0038Mixtures of anthraquinones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE CONTIENE COMO MINIMO UNA QUINONA Y A SU USO EN EL TRATAMIENTO DE ENFERMEDADES ESPECIALMENTE CANCER E INFECCIONES VIRICAS. LA COMPOSI CION DELA INVENCION CONTIENE AL MENOS UNA QUINONA DISUELTA ODISPERSA EN UN DILUENTE O VEHICULO LIQUIDO A UNA CONCENTRA CION DE UNOS 10^3 MOLES/LITRO O MENOR, PREFERIBLEMENTE HASTA 10^18 MOLES/LITRO. EN LA COMPOSICION LA QUINONA O COMO MINIMO UNA QUINONA ES PREFERIBLEMENTE: UNA ANTRAQUINONA GLUCOSIDA CON MAYOR PREFERENCIA ACIDO CARMINICO. ESTE COMPUESTOTIENE LA ESTRUCTURA QUIMICA CONTENIDA EN LA FICHA TECNICA.
GT199200009A 1991-02-13 1992-02-13 Composicion farmaceutica y su utilizacion en el tratamiento contra el cancer e infecciones viricas. GT199200009A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919103075A GB9103075D0 (en) 1991-02-13 1991-02-13 Trinitrobenzene derivatives and their therapeutic use

Publications (1)

Publication Number Publication Date
GT199200009A true GT199200009A (es) 1993-08-06

Family

ID=10689992

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199200009A GT199200009A (es) 1991-02-13 1992-02-13 Composicion farmaceutica y su utilizacion en el tratamiento contra el cancer e infecciones viricas.

Country Status (30)

Country Link
EP (1) EP0499467A3 (es)
JP (1) JPH06505231A (es)
CN (1) CN1064407A (es)
AP (1) AP549A (es)
AU (2) AU1233992A (es)
BG (1) BG61025B1 (es)
BR (1) BR9205642A (es)
CA (1) CA2104009A1 (es)
CZ (1) CZ166893A3 (es)
DZ (1) DZ1559A1 (es)
FI (1) FI933595A0 (es)
GB (2) GB9103075D0 (es)
GT (1) GT199200009A (es)
HU (1) HUT65634A (es)
IE (1) IE920464A1 (es)
IL (1) IL100906A (es)
IN (1) IN178929B (es)
IS (1) IS3814A (es)
JO (1) JO1719B1 (es)
LT (1) LT3197B (es)
MA (1) MA22443A1 (es)
MX (1) MX9200622A (es)
MY (1) MY131098A (es)
NO (1) NO932681L (es)
NZ (2) NZ240487A (es)
OA (2) OA09535A (es)
SK (1) SK87993A3 (es)
TN (1) TNSN92015A1 (es)
WO (1) WO1992014454A1 (es)
ZA (1) ZA921037B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
DZ1781A1 (fr) * 1993-05-21 2002-02-17 Radopah Ltd Agents d'arylation.
AP575A (en) * 1994-03-17 1997-01-31 Radopath Ltd Anti viral and anti cancer agents.
ATE188870T1 (de) * 1994-10-04 2000-02-15 Lohmann Rudolf Lomapharm Lösungen von anthrachinonen zur parenteralen applikation
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
JP2010535815A (ja) 2007-08-08 2010-11-25 バイオノボ・インコーポレーテッド モクセイ科トウネズミモチのエストロゲン性抽出物およびその使用
EP2190292A4 (en) 2007-09-07 2012-12-26 Bionovo Inc ESTROGENWIRKSAME EXTRACTS OF SCUTTELARIA BARBATA D. DON OF THE FAMILY LABIATAE AND ITS USES
CA2698732A1 (en) 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of astragalus membranaceus fisch.bge.var.mongolicus bge. of the leguminosae family and uses thereof
EP2194998A4 (en) 2007-09-07 2012-03-21 Bionovo Inc STROGENIC EXTRACTS OF ASPARAGUS CONCHINCHINENSIS (LOUR.) MERR OF THE LILIACEAE FAMILY AND USES THEREOF
EP2060562A1 (en) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
AU2008326426A1 (en) 2007-11-19 2009-05-28 Bionovo, Inc. Methods of detecting and treatment of cancers using scuttelaria barbata extract
US8197868B2 (en) 2007-11-19 2012-06-12 Bionovo, Inc. Process of making purified extract of Scutellaria barbata D. Don
EP2303249A4 (en) * 2008-06-06 2012-05-30 Bionovo Inc ANTHRAQUINONES AND ANALOGS FROM RHEUM PALMATUM FOR THE TREATMENT OF MEDIA CONDITIONS BY THE STROGEN BETA RECEPTOR
US9884815B2 (en) 2011-10-14 2018-02-06 Emory University PGAM1 inhibitors and methods related thereto
CZ304335B6 (cs) * 2012-02-22 2014-03-12 Mikrobiologický ústav AV ČR, v. v. i. Submerzní kmeny Quambalaria sp. CCM 8372 a CCM 8373, směs naftochinonových barviv jimi produkovaná, způsob jejich produkce a použití
US20210309860A1 (en) * 2018-07-17 2021-10-07 Pili Anthraquinonic derivatives and their use as colouring agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7708452L (sv) * 1977-07-22 1979-01-23 Allied Chem Komposition innehallande en antrakinonforening
JPS6054286B2 (ja) * 1979-09-18 1985-11-29 江澤 林 免疫増強剤
JPS6043210A (ja) * 1983-08-18 1985-03-07 Tdk Corp 磁気ヘツド及びその製造方法
DE3431236A1 (de) * 1984-08-24 1986-02-27 Carnivora-Deutschland GmbH, 7109 Jagsthausen Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation
DE3601065A1 (de) * 1986-01-16 1987-07-23 Behringwerke Ag Chinon-derivate als antitumormittel
EP0348509B1 (en) * 1987-12-10 1993-03-24 TSUMURA &amp; CO. Anti-retroviral drug
SG23618G (en) * 1988-08-16 1995-09-18 Wellcome Found Naphthoquinones for the treatment and prophylaxis of pneumocystis carinii infections
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
AU662883B2 (en) * 1990-04-03 1995-09-21 Radopath Limited Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
DE4013023A1 (de) * 1990-04-24 1991-11-07 Lohmann Rudolf Lomapharm Verwendung von anthrachinonderivaten zur prophylaxe und therapie von viruserkrankungen

Also Published As

Publication number Publication date
HU9302347D0 (en) 1993-10-28
NZ240487A (en) 1994-03-25
OA09810A (en) 1994-04-15
FI933595A (fi) 1993-08-13
ZA921037B (en) 1992-11-25
EP0499467A2 (en) 1992-08-19
IL100906A (en) 1996-09-12
JO1719B1 (en) 1992-12-15
BG61025B1 (bg) 1996-09-30
NO932681D0 (no) 1993-07-26
AP549A (en) 1996-11-01
MY131098A (en) 2007-07-31
OA09535A (en) 1992-11-15
EP0499467A3 (en) 1992-12-16
GB9203084D0 (en) 1992-03-25
IL100906A0 (en) 1992-11-15
IS3814A (is) 1992-08-14
NO932681L (no) 1993-10-07
MX9200622A (es) 1992-11-01
LT3197B (en) 1995-03-27
GB9103075D0 (en) 1991-03-27
DZ1559A1 (fr) 2002-02-17
TNSN92015A1 (fr) 1993-06-08
GB2254554B (en) 1995-09-20
CZ166893A3 (en) 1994-03-16
FI933595A0 (fi) 1993-08-13
IN178929B (es) 1997-07-19
HUT65634A (en) 1994-07-28
CA2104009A1 (en) 1992-08-14
LTIP329A (en) 1994-08-25
BR9205642A (pt) 1994-06-21
IE920464A1 (en) 1992-08-12
AU1233992A (en) 1992-09-15
WO1992014454A1 (en) 1992-09-03
BG98041A (bg) 1994-05-27
SK87993A3 (en) 1993-12-08
MA22443A1 (fr) 1992-10-01
NZ241593A (en) 1995-05-26
AP9200356A0 (en) 1992-04-30
GB2254554A (en) 1992-10-14
CN1064407A (zh) 1992-09-16
JPH06505231A (ja) 1994-06-16
AU5590696A (en) 1996-08-08

Similar Documents

Publication Publication Date Title
GT199200009A (es) Composicion farmaceutica y su utilizacion en el tratamiento contra el cancer e infecciones viricas.
ES2160623T3 (es) Composiciones farmaceuticas mejoradas para la penetracion en la piel de piroxicam.
ES2039898T3 (es) Acondicionamiento para una composicion liquida lista para su uso realizada a partir de una composicion liquida concentrada y procedimiento de realizacion.
ES2123721T3 (es) Formulaciones de rapamicina para inyecciones por via intravenosa.
UY25055A1 (es) Formulaciones farmacéuticas que contienen voriconazol
DK0971705T3 (da) Lægemiddelformuleringer til hormonerstatningsterapi til lokal påföring på huden
ES2052495T3 (es) Terapia de fluidos con aniones l-lactato y/o piruvato.
MX165724B (es) Pigmento constituido de particulas de rutilo tio(2) y composicion de revestimiento que lo contiene
ES2097548T3 (es) Suspensiones estables de microburbujas como agentes de intensificacion para ecografia ultrasonica.
CO4750836A1 (es) Nuevos medicamentos y utilizacion (1-metiletil)-8-azoniabiciclo-[3.2.1]octnao y su uso en pre- paraciones medicas
RU94029662A (ru) Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения
ES8104720A1 (es) Un procedimiento para la preparacion de composiciones lipo- somicas de substancias activas grasosolubles
BRPI0413957A (pt) processo para preparar diterpenos solúveis em água, solução aquosa e suas aplicações
ES2105519T3 (es) Vidrio absorbente de radiacion uv para lampara fluorescente.
ES2088138T3 (es) Mezclas estables de silice coloidal y un polimero formador de peliculas.
ES2071640T3 (es) Composicion blanqueante liquida acuosa.
AR247804A1 (es) Composicion biocida sinergica y metodo para proteger con la misma composiciones industriales
BR9509230A (pt) Processo e composição de agente de alvejamento
NO900152L (no) Dispenseranordninger drevet av flytende krystaller.
ES2082345T3 (es) Composicion del tipo de barra con cloruro de sodio y alcohol estearilico.
ES2041659T3 (es) Compuesto limpiador de tip liquido.
ATE202894T1 (de) Glutaraldehydzusammensetzung
Broszkiewicz The radiation-induced formation of NO3 in aqueous solutions
ES2120234T3 (es) Agente blanqueador.
ES8500746A1 (es) Metodo de producir una preparacion yodofora farmaceutica